Long Position on OPCH @ $19.25 on 1/25/2021 (Momentum)

Option Care Health, Inc. (OPCH) offers independent home and alternate site infusion services in the United States.

The company provides immunoglobulin infusion therapy designed for the treatment of immune deficiencies; anti-infective therapy and services; infusion therapies for bleeding disorders; and other infusion therapies to treat various conditions, including heart failure, pain management, chemotherapy, and respiratory medications.

It also offers home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases, as well as offers nursing services.

Option Care Health, Inc. has a collaboration with Amedisys, Inc. to provide COVID antibody infusion therapy within skilled nursing and assisted living facilities.

Following the company's successful issuance of $250 million in additional first lien term loans, the proceeds from which were used to extinguish the entire $246 million remaining outstanding balance of the Company’s second lien notes, this stock should see an increase in share prices.

Entry Point: $19.25

Stop Loss: $18.50

Trading Range: $5.74 - $19.90

Target Price: $21.45

Updates

3/31/2021 10:19:15 AM

OPCH closed at $18

Position closed on 3/31/2021 at price of $18.00 with a -6.49% loss in 65 days.

Back to Portfolio